Abstract
The present publication provides a process for the preparation of N- [5- [[4- [4- [(dimethyl amino) methyl]-3-phenyl-1H-pyrazol-1-yl] pyrimidin-2-yl] amino]-4-methoxy-2-(morpholin- 4- yl) phenyl] acrylamide mesylate represented by the following structural Formula I.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Anonymous, "Process for the preparation of Lazertinib Mesylate", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/10011
COinS